GEM 1.5 mg b.i.d. to 4.5 mg b.i.d. Versus Lorazepam in GAD (0777-026)
Status:
Completed
Trial end date:
2003-02-01
Target enrollment:
Participant gender:
Summary
This study will determine the effectiveness of MK0777 GEM versus Lorazepam in the treatment
of patients with generalized anxiety disorder.
This is an early phase trial and some specific protocol information is in progress and not
publicly available at this time. (Full information is available to trial participants).